SAN DIEGO, Calif.--Structural Bioinformatics here has signed an agreement with an unnamed Japanese pharmaceutical company to use its Dynapharm technology to design novel compounds. The Japanese partner has requested anonymity, according to Structural Bioinformatics officials.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.